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The organ of Corti, located within the mammalian cochlea, contains a precise mosaic of hair cells (HC)
and supporting cells (SC), the patterning of which is critical for auditory function. Progenitors of HCs
and SCs are found in the same post-mitotic region of the cochlear duct during early stages of cochlear
development, and both HCs and SCs are absent in mice lacking the transcription factor Atoh1. Based on
existing data, Atoh1 is thought to be the earliest determinant of HC fate, and to have a cell-autonomous
role in HC differentiation, but the lineage of Atoh1-positive cells within the cochlear duct remains
unclear. To address this issue, we used an inducible Atoh1CrenPR allele to permanently mark Atoh1-
expressing cells at different developmental time points. We found that up to 30% of cells from the
Atoh1-lineage develop as SCs, and that the number of Atoh1-positive SCs decreases both spatially and
temporally in a pattern consistent with ongoing commitment. Modulation of Notch signaling, necessary
for formation of the HC–SC mosaic, changes the percentage of cells from the Atoh1-lineage that develop
as either HCs or SCs. The HC–SC ratio is also affected by morphogenesis of the cochlea, as inhibiting the
outgrowth of the cochlear duct increases the number of Atoh1-lineage cells that develop as SCs. Our
results demonstrate that the Atoh1-lineage is established early in cochlear development, but also show
that expression of Atoh1 does not absolutely result in commitment to a HC fate.
Published by Elsevier Inc.Introduction
Proper auditory function depends on the formation of a highly
ordered mosaic of hair cells (HC) and supporting cells (SC) within
the organ of Corti (OC) of the mammalian cochlea. During develop-
ment, formation of a post-mitotic region of cells (zone of non-
proliferation), containing the progenitors of both HCs and SCs, ﬁrst
distinguishes these cells from other epithelial cells in the cochlear
duct (Chen and Segil, 1999). This region, called the prosensory
domain, becomes progressively more organized as formation of
the rows of inner and outer HCs proceeds, and the HC rows are
surrounded by several different types of supporting cells (Driver and
Kelley, 2009; Kelley, 2006). Because both HCs and SCs arise from
the same physical region of the cochlea, and both prosensory
progenitors and immature SCs can transdifferentiate into HCs under
some circumstances (Brooker et al., 2006; Kelley et al., 1995;Inc.
pment, National Institute on




ham and Women’s Hospital,Kiernan et al., 2005; Lanford et al., 2000; White et al., 2006), it has
been hypothesized that the prosensory domain represents a com-
mon progenitor population, and that subsequent expression of HC
and SC-speciﬁc genes differentiates prosensory cells into HCs or SCs.
Expression of the basic helix-loop-helix transcription factor
Atoh1 is thought to be the earliest determinant of HC fate.
Absence of Atoh1 results in a complete loss of both HCs and SCs
(Bermingham et al., 1999; Chen et al., 2002), and forced expres-
sion of Atoh1 in nonsensory cells within the cochlear duct induces
ectopic HCs (Gubbels et al., 2008; Woods et al., 2004; Zheng and
Gao, 2000). However, there has been some debate regarding
the full extent of changes in the organ of Corti in response to
deletion of Atoh1. Some studies have concluded that some level of
differentiation is retained in Atoh1/ cochleae. These conclu-
sions are based on either morphological criteria or expression of
molecular markers, including Bdnf, Sox2, Prox1, and Jag1, which
are expressed speciﬁcally in HCs (Bdnf) and SCs (Sox2, Prox1,
Jag1) in the late post-natal cochlea (Fritzsch et al., 2005; Dabdoub
et al., 2008). However, none of these factors can be strictly
considered as a marker of differentiation, as all are initially
expressed in undifferentiated cochlear prosensory cells (Kiernan
et al., 2005; Morrison et al., 1999; Bermingham-McDonogh et al.,
2006; Farin˜as et al., 2001). As a result, their continued expression
in the epithelium may be an indicator of persistent prosensory
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suggested that the extension of spiral ganglion ﬁbers into the
cochlea in Atoh1 mutants is an indication of some degree of
cellular differentiation (Fritzsch et al., 2005), but since both Bdnf
and Nt3 are expressed in the cochlear duct prior to Atoh1
expression (Farin˜as et al., 2001), it seems unlikely that further
differentiation would be required for ﬁber extension. Regardless,
since Atoh1 is clearly both necessary and sufﬁcient for HC
development, it has been the focus of extensive research within
the auditory ﬁeld. But, despite multiple publications, the speciﬁc
role of Atoh1 remains unclear.
At early stages of cochlear development in the mouse, prior to
embryonic day 15 (E15), both Atoh1 transcript and an Atoh1lacZ
knock-in reporter indicate broad expression within the cochlea.
But beginning around E15, expression is found only in HCs
(Woods et al., 2004; Yang et al., 2010). This apparent reﬁnement
of Atoh1 expression over developmental time is consistent with
the pattern of expression of genes with proneural function, such
as Drosophila atonal and achaete-scute (Jarman et al., 1993) and
had led to the suggestion that Atoh1 acts a proneural, or, more
accurately, pro-hair cell gene within the cochlea (Lanford et al.,
1999; Woods et al., 2004) with the effect of its expression being to
initiate a HC developmental program. This hypothesis is sup-
ported by the increased number of HCs observed in the cochlea in
response to deletion of known or likely antagonists of Atoh1, such
as the transcription factor Sox2 (Dabdoub et al., 2008) and the
Notch signaling pathway (Brooker et al., 2006; Kiernan et al.,
2005; Lanford et al., 1999). In addition, several Atoh1-reporter
lines have indicated expression in some supporting cell types, an
effect that is consistent with an initial broad expression (Matei
et al., 2005; Yang et al., 2010). In contrast, localization of ATOH1
by immunohistochemistry or in several other Atoh1-transgenic
reporter lines indicated only hair cell-speciﬁc expression of Atoh1,
leading to the suggestion that ATOH1 acts as a differentiation
factor, with expression that is limited to prosensory cells that are
already committed to a hair cell phenotype (Chen et al., 2002;
Fritzsch et al., 2005; Pan et al., 2011). This conclusion is supported
by the relatively normal development of the cochlea prior to the
onset of Atoh1 expression, and indications of cellular organization
and the presence of supporting cells in vestibular epithelia even
in the absence of Atoh1, as previously discussed (Bermingham
et al., 1999; Fritzsch et al., 2005).
Finally, Atoh1 expression has also been reported in spiral
ganglion neurons, suggesting possible early expression in a
hypothesized neurosensory progenitor (Matei et al., 2005). How-
ever, some of these data were derived using a transgenic mouse
line that has been reported to include ectopic expression (Lumpkin
et al., 2003) and several studies from other laboratories have failed
to replicate this ﬁnding (Basch et al., 2011; Lu et al., 2011;
Yamamoto et al., 2011; Yang et al., 2010). To more directly
examine the expression pattern of Atoh1 in the developing cochlea,
we used an inducible Atoh1CrenPR knock-in allele (Rose et al., 2009)
to mark the cochlear lineage of Atoh1-mRNA expressing cells at
different developmental time points. Our results indicate that early
in cochlear development, up to 30% of cells that initiate Atoh1
promoter activity develop as SCs rather than HCs, consistent with a
proneural role for Atoh1. In addition, labeling of Atoh1-expressing
cells at later developmental time points revealed a rapid down
regulation of Atoh1 promoter activity and subsequent protein
expression that contrasts with previous results. Positive or nega-
tive modulation of the Notch signaling pathway increases or
reduces the percentage of SCs in the Atoh1-lineage, respectively,
demonstrating for the ﬁrst time that Notch signaling can inﬂuence
cells within the cochlea that are already positive for Atoh1. Finally,
inhibition of cochlear duct extension also alters the ratio of Atoh1-
expressing HCs to SCs, demonstrating that spatial rearrangementsinvolved with growth of the cochlear duct serve an important role
in cellular patterning within the sensory epithelium.Materials and methods
Mice
Male mice carrying both the Atoh1CrenPR and a reporter allele,
R26RlacZ, or R26RtdTomato (Madisen et al., 2010; Rose et al., 2009;
Soriano, 1999) were mated with CD1 females (Charles River). In
vivo RU486 injections into pregnant females were performed as
previously described (Rose et al., 2009). All mice were maintained
according to animal care and use protocols of the either the
Center of Comparative Medicine of Baylor College of Medicine or
the National Institutes of Health.
Cochlear explant cultures
Embryos were collected from timed pregnant females and
cochlear explant cultures established between embryonic day 13
(E13) and post-natal day 0 (P0) as previously described (Driver and
Kelley, 2010; Montcouquiol and Kelley, 2003; Yamamoto et al.,
2009). RU486 (Mifepristone, Sigma) was dissolved in DMSO and
added to the culture media at the indicated concentration
for 1, 4, or 24 h; the total DMSO concentration was less than or
equal to 0.2%. The RU486-containing media was then removed and
replaced with control media after rinsing, and the explants cultured
for another 4–6 DIV. DAPT and blebbistatin were both from EMD.
Recombinant mouse DLL1-Fc chimeric protein was obtained from
R&D Systems, and added at 1.25, 2.5, 5, or 10 mg/ml. Paired controls
were treated with the equivalent concentration of control IgG2A Fc
protein. For blebbistatin-treated explants, cochleae were bisected at
approximately 50% of the cochlear length, and only the basal portion
of the explant was cultured.
Gene expression analysis and immunohistochemistry
Whole mount cochleae and cochlear explants were ﬁxed in 4%
paraformaldehyde. Staining for b-galactosidase activity was per-
formed as previously described (Rose et al., 2009). Antibodies
used were as follows: anti-dsRed (Clontech), anti-MyosinVI (Pro-
teus Biosciences), anti-MyosinVIIa (Developmental Studies Hybri-
doma bank), anti-Sox2, (Santa Cruz), anti-p75NTR and anti-Prox1
(Covance), and anti-S100A1 (Thermo Scientiﬁc). All secondary
antibodies and labeled phalloidin were from Invitrogen. Atoh1
mRNA expression was determined by in situ hybridization as
previously described (Driver et al., 2008).
For determination of relative expression levels of Atoh1, wild-
type cochleae were dissected at E13, E15, P0, and P5. Cochleae
were treated with thermolysin to separate the tissue layers, and
the epithelia were manually dissociated. For P0 samples, only the
most apical and basal quadrants of the epithelia were collected.
At least three independent samples from each stage, composed of
tissue pooled from 3 or 4 cochleae, were compared in the qPCR
analysis. E15 was used as the reference sample. The relative
level of MyoVI was also determined as a positive control for the
presence of HCs. Hes1 and Hes5 relative expressions were deter-
mined from wild-type E13 CD1 cochlear explants treated with
5 or 10 mM blebbistatin or 0.1% DMSO (control), beginning after
1 DIV, for a total of 6 DIV. Total RNA was extracted using the
Arcturus Picopure kit (Applied Biosystems). Relative gene expres-
sion levels were determined using TaqMan gene expression
assays (Applied Biosystems) and the DDCT method, with Gapdh
as an internal control. Statistically signiﬁcant different levels of
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Tukey’s test.
Anti-ATOH1 polyclonal antibody and immunohistochemistry
A chicken anti-peptide antibody (Aves Labs) was generated
against a synthetic peptide corresponding to amino acids 330–
351 of mouse ATOH1 (CZRSHRSDGEFSPHSHYSDSDEAS). The anti-
body was afﬁnity puriﬁed, then diluted to 1.5 mg/ml. During the
optimization of staining procedures with this antibody, we found
that it provides optimal detection of ATOH1 in brieﬂy ﬁxed tissue.
Wild type E14-P0 mouse cochleae for sections were ﬁxed for
30 min in 4% paraformaldehyde prior to embedding. For blocking,
samples were treated with a combination of 10% normal goat
serum and 10% Henblocker reagent (Aves Labs). Anti-ATOH1 was
added at 150–300 ng/ml (1:10,000–1:20,000) overnight at 4 1C.
Sections were rinsed extensively prior to incubation with anti-
chicken secondary antibodies.
Analysis of cell fate
The lengths of cochlear explants were measured along the IHC
row, and confocal Z-stack images taken at 5, 25, 50, 75, and 95% of
the total length. For the bisected explants used in the blebbistatin
treatment experiments, cells were counted at the 5, 50, and 95%
positions (equivalent to 5, 25, and 50% positions of intact explants).
All tdTomato-positive cells of the sensory epithelium within the
image ﬁeld (approximately 200 mm wide) at each distance were
counted, and classiﬁed as IHCs, OHCs, ISCs, or OSCs. The total
number of HCs (MyoVI or MyoVIIa-positive cells) was also deter-
mined. Data are the average percentage of cell type found, plus
or minus standard error of the mean (SEM). Results are from at least
three separate experiments, with at least two explants from
each experiment. Statistical signiﬁcance of changes in cell fate wasFig. 1. In vivo induction of Atoh1Cre*PR labels both hair cells and supporting cells. A. Surf
at P0. Atoh1 is only found in HCs. Scale bar (same for (B, D), 20 mm). B-C. b-galactosidase
into pregnant females from 9.5 to 17.5 dpc, then cochleae were dissected and stained
High magniﬁcation of a b-galactosidase-positive OHC (arrow). Scale bar (same for (E–G
activity was induced with a single injection of RU486 at 14.5 dpc. Both IHCs (arrows
tdTomato-positive cells from the Atoh1-lineage. IHCs and OHCs are labeled (arrows), as
and position between OHCs. F, G. Z-stack confocal projections. F. One IHC and one O
tdTomato-positive (arrows). A Dieters’ cell is also labeled by tdTomato (arrowhead), an
and inner phalangeal cell (arrowhead). MyosinVI (green) labels all HCs.determined by two-tailed paired student’s t-test. Statistical signiﬁ-
cance of differences among SCs and HCs at different basal-to-apical
positions was determined using one-way ANOVA followed by
Tukey’s test.Results
In vivo induction of Atoh1CrenPR indicates that supporting cells arise
from the Atoh1 lineage
To determine whether the Atoh1 promoter is ever active in
cells that do not differentiate into hair cells, we used an inducible
Atoh1CrenPR knock-in allele (Rose et al., 2009) crossed to either the
R26RlacZ or R26REYFP Cre reporter alleles to permanently mark cells
of the Atoh1 lineage. We induced activity of CrenPR by adminis-
tering RU486 to pregnant females at a variety of different time-
points when differentiation of cells within the cochlea is known
to occur. In contrast to the Atoh1lacZ knock-in reporter allele
((Bermingham et al., 1999); Fig. 1A), in which virtually all hair
cells are positive for b-galactosidase at P0, only a few cells in the
Atoh1CrenPR; R26RlacZ cochlea showed evidence of b-gal activity
when examined at P0 (Fig. 1B). This was the case whether CrenPR
activity was induced by repeated low-dose RU486 injections over
several days (e.g. from E9.5 to E17.5) or higher-dose injections on
a single day (due to the stochastic and dose-dependent nature of
CrenPR induction). Most of the b-gal-positive cells were HCs,
identiﬁable by their shape and position within the OC (Fig. 1B, C).
Similar results were obtained in Atoh1CrenPR; R26RtdTomato cochleae
(Fig. 1D). However, some labeled cells appear to be SCs based on
their morphology and position in the OC matrix. For instance, in
Fig. 1E, one tdTomato-positive SC (arrowhead), presumably a
Dieters’ cell based on its position between the second and third
rows of OHCs, is present. Other examples of tdTomato-labeled SCsace view of the base of the cochlear epithelium from an Atoh1lacZ knock-in reporter
activity in in vivo induced Atoh1Cre*PR; R26RlacZ cochleae. RU486 was injected daily
at P0. B. Low magniﬁcation view, similar to (A). Few cells in the OC are labeled. C.
), 10 mm). D. Low magniﬁcation view of an Atoh1Cre*PR; R26RtdTomato cochlea. Cre*PR
) and OHCs (open arrows) are tdTomato-positive. E. High magniﬁcation view of
well as one SC, identiﬁable as a Dieters’ cell (arrowhead) based on its morphology
HC, identiﬁed by position and phalloidin-labeled stereocilia bundles (green), are
d has a strongly Sox2-positive nucleus (blue). G. tdTomato-positive OHC (arrow),
E.C. Driver et al. / Developmental Biology 376 (2013) 86–98 89are shown in Fig. 1F and G. The low number of labeled cells in all
cochleae examined is likely due to inefﬁcient activation of the
CrenPR protein in the inner ear. The difference between the rates
of R26R recombination in the cochlea compared to the brain (Rose
et al., 2009) may be caused by the relatively limited vascular
perfusion in the cochlea at these stages, which could restrict the
amount of RU486 that reaches the cells in the developing OC.Supporting cells are found in the Atoh1-lineage in cochlear explants
Because so few cells were labeled by in vivo induction of
CrenPR activity, which precluded meaningful statistical analysis
of the number of labeled SCs, we used a cochlear explant protocol
(Montcouquiol and Kelley, 2003) and the sensitive Cre-activated
R26RtdTomato reporter allele to increase the number of labeled cells
(Madisen et al., 2010). Atoh1CrenPR/þ ; R26RtdTomato/þ cochlear
explants were established, usually at E13, and CrenPR activity
was induced with RU486 at speciﬁc time-points and for different
durations of the culture period. We found that cochlear hair cells
were tdTomato-labeled in a dose-dependent manner. In cochlear
explants treated with high concentrations of RU486 (1 mM or
100 nM) for 24 h beginning at E13, nearly all hair cells (identiﬁed
by co-expression of MyoVI) were tdTomato-positive (Fig. 2A–G).
However, a signiﬁcant number of tdTomato-positive cells within
these explants developed as SCs rather than HCs. In explants treatedFig. 2. Atoh1-expressing cells develop as both hair cells and supporting cells. Atoh1Cre
culture and maintained for 6 DIV. A–C. Low magniﬁcation views. A. Most HCs along t
labeling of HCs in the same cochlear explant (green). C. Merge of (A) and (B) shows over
magniﬁcation views labeled as in (A–C). Nearly all HCs are tdTomato-positive, althou
tdTomato-positive cells have a SC morphology and are negative for MyoVI (open arrow
positive) also expressing tdTomato in cochlear explants treated with the indicated conce
as SCs following treatment with the indicated concentrations of RU486. I. Z-stack confo
in the nuclei of supporting cells. Open arrowheads indicate tdTomato-labeled supportinwith 1 mM or 100 nM RU486 the number of tdTomato-positive cells
SCs comprised just over 30% of the total tdTomato-positive cells
(Fig. 2D-F, H). With lower doses of RU486, both the total number of
labeled HCs and the percentage of tdTomato-labeled cells that
developed as SCs decreased (Fig. 2G, H); no tdTomato-expressing
cells were ever observed in the absence of RU486.
We identiﬁed SCs based on multiple criteria: cell morphology
(nuclei located in the basal layer and a thin projection to the lumenal
surface of the epithelium), negative staining for MyosinVI or Myo-
sinVIIa, strong expression of Sox2 in the nucleus (Fig. 2D–F, I, open
arrowheads), and the absence of a stereocilia bundle (Fig. 3A–C). To
further conﬁrm that these tdTomato-positive cells developed as SCs,
we evaluated the expression of other SC markers. tdTomato-labeled
cells with SC morphology found between the IHC and OHC rows
were also positive for p75NTR, a marker of pillar cells (PCs, Mueller
et al., 2002, Fig. 3D–F). Labeled SCs located in the OHC region also
expressed Prox1 and S100A1, both normally expressed by Dieters’
cells (Bermingham-McDonogh et al., 2006), whereas those SCs
adjacent to the IHC row were negative for both Prox1 and S100A1
(Fig. 3G–L).
To determine whether Atoh1 expression in SCs decreases over
developmental time, RU486 was applied at later stages. In con-
trast to the 30.372.1% of labeled cells that developed as SCs in
explants established at E13, when RU486 was applied for 24 h
starting at E15, only 6.970.9% of tdTomato-positive cells devel-
oped as SCs (Fig. 4A–C). For E17, the number of SCs dropped to*PR; R26RtdTomato cochlear explants established at E13, induced for the ﬁrst 24 h in
he length of the explants are tdTomato-positive (magenta). B. MyosinVI (MyoVI)
lap (white) of tdTomato and MyoVI labeling. Scale bar, (A–C), 200 mm. D–F. Higher
gh MyoVI labeling indicates a few HCs that are not (arrows). In addition, some
heads). Scale bar, (D–F), 25 mm. G. The average percentage of total HCs (MyoVI-
ntrations of RU486. H. The percentage of total tdTomato-positive cells that develop
cal projection of cells from a similar explant as in (A–F). Sox2 is strongly expressed
g cells with bright Sox2-positive nuclei and lumenal projections. Scale bar, 10 mm.
Fig. 3. tdTomato-labeled cells express markers of supporting cells. Atoh1Cre*PR; R26RtdTomato cochlear explants established at E13, treated with 10 nM RU486 for the ﬁrst
24 h in culture, and maintained for 6 DIV. tdTomato-positive cells are shown in red, and HCs are marked with MyoVI or MyoVIIa (blue). Open arrowheads indicate
tdTomato-labeled cells with SC morphology. A. Shallow confocal Z-stack projection of the lumenal surface of a cochlear explant. Three tdTomato-positive, MyoVI-negative
cells are shown. B. F-actin-rich stereocilia bundles present on HCs are stained with phalloidin (green). C. Merge of (A) and (B). The tdTomato-labeled cells lack stereocilia
bundles (open arrowheads). D. A single MyoVIIa-negative cell is present between the IHC and OHC rows (open arrowhead). E. Pillar cells are labeled with anti-p75NTR
(green). F. Merge of (D) and (E). p75NTR labeling coincides with tdTomato staining. D0-F0 . Z-stack confocal reconstructions from the images shown in (D-F). The XY location
of the Z-stack is indicated by the brackets in (D–F). The p75NTR and tdTomato-positive, MyoVIIa-negative cell has characteristic PC location and morphology. G. Several
tdTomato-positive, MyoVIIa-negative cells in the OHC or PC region (open arrowheads), or IHC region (arrow) are shown. H. Anti-Prox1 staining in the nuclei of SCs in the
OHC and PC regions (green). I. Merge of (G) and (H). tdTomato-labeled cells found near OHCs and PCs are Prox1-positive (open arrowheads), but a labeled SC adjacent
to the IHCs is Prox1-negative (arrow). J. Z-stack confocal reconstruction showing two tdTomato-positive SCs. K. S100A1 marks the IHCs, PCs, and Dieters’ cells (green).
L. Merge of (J) and (K). The SC next to the IHCs is S100A1-negative (arrow), but the tdTomato-positive outer PC is S100A1-positive (open arrowhead).
E.C. Driver et al. / Developmental Biology 376 (2013) 86–98901.470.7%. This result is consistent with a rapid down-regulation
of Atoh1 in cells that will develop as SCs.
Cellular commitment occurs in basal-to-apical and medial-to-lateral
gradients
Several aspects of cellular differentiation within the OC have
been described as occurring in gradients that extend from base toapex. To establish whether determination of cell fate follows a
similar pattern, we next examined whether the fates of Atoh1-
expressing cells vary along the long axis of the cochlea over
developmental time. When RU486 induction was started at E13,
the percentage of labeled SCs was fairly constant regardless of
basal-to-apical location, which is consistent with a rapid onset of
Atoh1 mRNA expression from base to apex. However, a develop-
mental gradient was apparent when induction was started at E15
Fig. 4. Cell fate speciﬁcation occurs in a basal to apical gradient. A. Low magniﬁcation view of an Atoh1Cre*PR; R26RtdTomato cochlear explant established at E15 and
maintained for 4 DIV. RU486 was added for the ﬁrst 24 h of culture. The positions along the cochlear length at which cells were counted are indicated. Scale bar, 200 mm. B.
Image taken at 5% of the cochlear length, measured from the base. With few exceptions (arrows), MyoVIIa-positive HCs are also tdTomato-positive. Few tdTomato-labeled
SCs are seen, and those present are mostly found near the rows of OHCs (OSCs, open arrowheads). Only one ISC is observed in this ﬁeld (closed arrowhead). Scale bar (same
for C), 25 mm. C. Image from the 95% position. Many more labeled ISCs (closed arrowheads) are visible, along with several tdTomato-positive OSCs (open arrowheads).
Arrows indicate unlabeled HCs. D. The percentage of total tdTomato-positive cells that develop as SCs at each position along the cochlear length, from base to apex, at E15.
More labeled SCs are found at apical positions. E. Relative percentages of total tdTomato-labeled SCs that develop as either ISCs or OSCs, based on position along the duct.
The percentage of ISCs increases toward the apex.
E.C. Driver et al. / Developmental Biology 376 (2013) 86–98 91(Fig. 4A–D). In comparison to the most basal region, the percentage
of tdTomato-positive cells that developed as SCs was 6 times greater
at the most apical position (Fig. 4D). In E17 induced explants,
tdTomato-positive SCs were restricted entirely to the apical-most
(95%) portion of the cochlea, and even in that region the total
number of labeled SCs had decreased to 5.872.1% (not shown).
In addition to the developmental gradient from the base to
apex of the OC, at any position along that axis, cell fate determi-
nation is also thought to occur in a gradient that extends along
the medial-to-lateral (IHC to OHC) axis as well. To examine this,
tdTomato-labeled SCs along the length of the cochlea were
classiﬁed as either inner supporting cells (ISCs), which included
phalangeal cells, border cells, and inner pillar cells, or OSCs, which
included outer pillar cells, Dieters’ cells, and Hensen’s cells, at
different positions along the basal-to-apical axis in explants
treated with RU486 starting on E15. Consistent with the hypoth-
esis that medially positioned cells of the organ of Corti are
speciﬁed prior to laterally positioned cells, a much higher per-
centage of Atoh1-labeled SCs were observed in the OSC region in
the base of the cochlea while in the apex the ratio of labeled
ISC:OSC approached 1:1 (Fig. 4E).As discussed, treatment with RU486 for 24 h at E13 resulted
in uniform labeling of hair cells, therefore 1 and 4 h treatments of
1 nM RU486 at E13 were used in an effort to determine whether
the onset of Atoh1 expression occurs in a gradient or not. Following
either a 1 or 4 h pulse of RU486, a slight, but not statistically
signiﬁcant, basal-to-apical gradient in the percentage of tdTomato-
positive HCs was observed (Fig. 5A–C). However, the highest
percentage of tdTomato-positive cells was observed at the 25%
from the base position rather than at the 5% position (Fig. 5A, C),
indicating either a higher number of Atoh1-expressing cells, or cells
expressing a higher level of Atoh1, or both, at that location. This
result is consistent with previous studies that have shown the
earliest markers of cell differentiation not at the extreme base but
slightly more apically (Rubel, 1978). In contrast, we did not detect
any differences in the proportion of IHCs versus OHCs that were
labeled at any position along the cochlear duct, and so did not
observe a gradient in HC labeling along the IHC to OHC axis. It may
be that the temporal resolution of Atoh1CrenPR induction by RU486
is insufﬁcient to detect this gradient, or the gradient may not exist.
Interestingly, some tdTomato-positive OHCs were present at the
most apical positions of the cochlear duct even following a 1 h
Fig. 5. HCs along the length of the cochlea are Atoh1-positive at E13. A,B. Images
from an Atoh1Cre*PR; R26RtdTomato cochlear explant established at E13, treated with
1 nM RU486 for 1 h, and then maintained for an additional 6 DIV. A. Image from
the 25% position. The highest percentage of tdTomato-labeled cells is found in this
mid-basal region. B. Image from the 95% position. Some OHCs are found in
the Atoh1-lineage, even after only a 1 h RU486 treatment at E13 (arrows). C. The
average percentage of MyoVIIa-positive HCs also labeled with tdTomato in
explants treated with 1 nM RU486 for either 1 or 4 h at E13. Differences among
the percentage of labeled cells at each position are not statistically signiﬁcant from
one another.
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the cochlear that will develop as OHCs are already positive for
Atoh1 at that time, and will be maintained in an undifferentiated
state for several days.
Atoh1-promoter activity is rapidly down-regulated
in developing hair cells
Previous assessments of the duration of Atoh1-expression in
developing hair cells have obtained differing results, with some
studies indicating down-regulation in the early postnatal period
(Lanford et al., 2000) while others reported Atoh1 expression into
adulthood (Matei et al., 2005). To examine when Atoh1 expression
becomes down-regulated in HCs in this mouse model, the
percentage of labeled HCs was examined following induction of
CrenPR at different developmental ages. As discussed, induction of
CrenPR at a concentration of 100 nM RU486 at E13 resulted in an
average of 98% of HCs being labeled (Fig. 2G). The same inductionregime at E15 marked only 89% of the HCs, suggesting that some
cells were already negative for Atoh1, but that most HCs were still
expressing Atoh1. However, by E17 only about half of the HCs
were labeled, and this number was further reduced to a quarter
of HCs at P0 (Fig. 6A). Parsing of these data based on spatial
distribution along the basal-to-apical axis revealed a pronounced
gradient in the down-regulation of Atoh1-promoter activity
(Fig. 6B). At E17, the gradient of tdTomato-positive HCs increased
from a minimum of 20% of total hair cells in the base to 80% of
total HCs in the apex (Fig. 6B). By P0, 80% of HCs in the apex were
still labeled while virtually no labeled HCs were observed in the
base (Fig. 6D–G). In contrast with the onset of Atoh1 promoter
activity, which occurs nearly simultaneously along the length of
the cochlea (Fig. 5), the down-regulation of Atoh1 expression
occurs in a pronounced basal-to-apical gradient.
ATOH1 protein is absent from HCs by P5
The results presented above suggested a rapid decrease in
Atoh1-promoter activity that contrasts with previous reports. To
determine whether this decrease in promoter activity leads to
a decrease in ATOH1 protein, we generated an antibody against
ATOH1 that speciﬁcally labels HC nuclei. ATOH1-positive cell
nuclei were ﬁrst detectable in cochlear sections at E14 (Fig. 7A),
in positions that approximate the locations of developing IHCs,
and are consistent with previous results from reporter lines (Chen
et al., 2002; Lumpkin et al., 2003). By E16, strong expression of
ATOH1 protein was observed in all HCs in both the apex and the
base of the cochlea (Fig. 7B, C). In contrast, in P0 cochlear sections,
ATOH1 expression in HCs at the base of the cochlea was nearly
undetectable, though the staining was still strong in HCs at the
apex (Fig. 7D, E). These data are consistent with the observed
decrease in Atoh1 promoter activity in Atoh1CrenPR cochleae and
suggest that ATOH1 protein is rapidly down-regulated in a basal-
to-apical gradient beginning by P0 (Fig. 6). However, mRNA for
Atoh1 is still detectable in both the apex and the base of the
cochlea at P0, although the level of expression does appear to be
somewhat reduced in the base (Fig. 7G, H). By P5, all HCs were
negative for ATOH1 protein (Fig. 7I). We obtained similar results
from quantitative RT-PCR (qPCR) for Atoh1 performed on isolated
cochlear epithelia at the same ages (Fig. 7M), which showed that
the level of Atoh1 in the P0 base is signiﬁcantly lower compared to
E15, and is almost undetectable at P5 (po0.01). Speciﬁcity of the
ATOH1 antibody was conﬁrmed using cochlea from Atoh1lacZ/lacZ
embryos (Fig. 7L), which lack the entire Atoh1 coding domain
(Ben-Arie et al., 1997).
Notch signaling regulates Atoh1-cell fate
Notch signaling plays a key role in determining the number of
hair cells that form within the organ of Corti. However, it has not
been resolved whether Notch signaling speciﬁcally regulates the
expression of Atoh1 (Chen et al., 2002). To determine whether
activation of Notch signaling induces Atoh1-expressing cells to
develop as SCs, the percentage of tdTomato-positive cells that
develop as SCs was assayed following inhibition of Notch signaling
using a g-secretase inhibitor N-[(3,5-Diﬂuorophenyl)acetyl]-L-ala-
nyl-2-phenyl]glycine-1,1-dimethylethyl ester (DAPT). E13 explants
were treated with 10 nM RU486 for 24 h to label all cells expres-
sing Atoh1 during that time. 50 mM DAPT was then added begin-
ning at 3 DIV, equivalent to E16. The addition of DAPT was delayed
in order to allow any residual RU486 to be completely cleared, so
that cells newly expressing Atoh1 would not be tdTomato-positive.
In cochlear explants treated with DAPT, the percentage of labeled
SCs decreased to 5%, as compared to about 20% in paired controls
(po0.0001), consistent with a conversion of most SCs from the
Fig. 6. Atoh1 expression in hair cells decreases over developmental time. A. The average percentage of MyoVIIa-positive HCs that are also positive for tdTomato in cochlear
explants treated with 100 nM RU486 for 24 h at E13, E15, E17, or P0. B. Same data as in (A), but shown as measured at each position along the cochlear length, from base to
apex. More tdTomato-positive cells are found at the apex. C-D. Low magniﬁcation images from an Atoh1Cre*PR; R26RtdTomato explants treated with RU486 at E17 (C) and P0
(D), stained for MyoVIIa (green) and tdTomato (magenta). E-G. High magniﬁcation views of the explant in (D). E. At 5% of the cochlear length from the base, no tdTomato-
positive cells are observed. F. A few tdTomato-labeled cells are present at the 50% position. G. Most but not all (arrows) MyoVIIa-positive HCs are also tdTomato-labeled at
the 95% position. A single SC is tdTomato-positive (open arrowhead).
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increase in the number of tdTomato-negative HCs was observed in
DAPT-treated explants, suggesting that unlabeled, previously
Atoh1-negative, SC progenitors were also converting to a HC fate
in response to inhibition of Notch signaling (Fig. 8D, po0.001). The
total number of tdTomato-positive cells was not signiﬁcantly
different between control and DAPT-treated explants.
Conversely, in explants with increased levels of Notch signaling
as a result of treatment with a soluble form of the Notch ligand
Delta-like1 (DLL1), the percentage of tdTomato-positive cells that
developed as SCs increased. Recombinant DLL1-Fc chimeric protein
was added at varying concentrations beginning at E14, after
explants had been treated for 24 h with 10 nM RU486. A small
but statistically signiﬁcant increase in the percentage of labeled
SCs was observed in explants treated with 2.5, 5, or 10 mg/ml of
DLL1-Fc, as compared to paired controls treated with an equivalent
concentration of control Fc protein, with an average increase from
19.7% to 23.3% (Fig. 7C–F, po0.005). We also observed a smalldecrease in the percentage of tdTomato-labeled HCs (Fig. 8E,
po0.005). This result demonstrates that treating cochlear explants
with exogenous DLL1-Fc causes some Atoh1-expressing cells that
had been fated to become HCs to be converted to SCs, although
fewer cells were converted from HC to SC than were converted
from SC to HC by the addition of DAPT, perhaps because it is more
difﬁcult to convert a committed HC to a SC, as compared to
converting a less-committed SC to a HC.
Inhibition of cochlear outgrowth increases the number
of Atoh1-expressing SCs
Because growth, morphogenesis, and patterning of the cochlea
all occur simultaneously, we hypothesized that disrupting the
outgrowth of the cochlear epithelium might also inﬂuence cell
fate decisions, possibly as a result of changes in Notch signaling
caused by altered cell–cell interactions. Extension of the cochlear
duct had been previously shown to depend on the activity of
Fig. 7. ATOH1 protein expression. A. Section from the base of an E14 cochlea. Three
ATOH1-positive nuclei are present (red, arrows). B–F, I. Sections from cochleae at the
indicated ages, stained with antibodies against ATOH1 (red) and MyoVI (green).
F-actin stained by phalloidin is shown in blue. B, C. E16 cochlea. Strong staining for
the ATOH1 antibody is present in all HCs (also positive for MyoVI), at both the apex
and the base. D–F. P0 sections. D. Lowmagniﬁcation view of two turns of the cochlea.
MyoVI staining marks HCs in the apex and base (arrows). Non-speciﬁc background
staining from the ATOH1 antibody is present on the surface of the stria vascularis
(open arrowheads). E. Apical section from (D). Strong ATOH1 signal is present in the
OHCs (bracket), but slightly weaker staining is found in the IHC (arrow). F. ATOH1
staining is almost absent in a section from the base at P0 in both the IHC and OHCs. G,
H. In situ hybridizations for Atoh1 transcript. Atoh1 mRNA is still present at the apex
(G) and base (H) of a P0 cochlea. I. ATOH1 protein is not detectable at the apex of the
cochlea by P5. J. ATOH1 protein (red) in the mid-base of an E16 Atoh1þ /þ cochlea. K.
Same section as in (J), also showing MyoVI staining (blue), weak Sox2 staining in the
HC nuclei, and strong Sox2 staining in the SC nuclei (green). L. In a section from an
E16 Atoh1/ cochlea, no reactivity for either ATOH1 (red) or MyoVI (blue) is visible.
Sox2-positive cells remain (green). M. Relative expression levels of Atoh1 and MyoVI
in the cochlear epithelium at E13, E15, P0, and P5 as determined by qPCR. Values are
presented as relative to E15. Error bars represent SEM. *po0.01.
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pharmacological inhibitor blebbistatin (Yamamoto et al., 2009).
Therefore, E13 cochlear explant extension assays were estab-
lished as described previously (Wang et al., 2005; Yamamoto
et al., 2009). Explants were treated for 24 h with RU486 and then
cultured with or without 10 mM blebbistatin for the remaining
5 DIV. As expected, explants treated with blebbistatin were much
shorter than paired controls (Fig. 9A, B), and the pattern of the
sensory epithelium was disrupted, lacking the normally ordered
rows of cells (Fig. 9C, D). In addition, the percentage of tdTomato-
positive SCs increased from 8% in controls to 12% in paired
blebbistatin explants (Fig. 9E, po0.005). The lower percentage
of labeled SCs in both controls and blebbistatin-treated explants
(compared to other explants treated with 10 nM RU486) is likely
due to the removal of the apical portion of the cochlea (which
contains more tdTomato-positive SCs) as a pre-condition for the
extension assay. This result demonstrates a role for cochlear
outgrowth in the determination of cell fates within the OC.
One possible explanation for the increase in Atoh1-positive SCs
could be aberrant Notch-mediated lateral inhibition; since the
cochlear epithelium fails to extend normally, the cells of the
epithelium remain at a higher density with a greater number of
cell–cell contacts. As a result, Atoh1-positive cells that would
normally be fated to become HCs may remain in contact with
other Atoh1-positive cells that have already begun to express the
Notch ligands DLL1 and JAG2. Prolonged contact could lead to
increased levels of Notch signaling and therefore to a conversion
to a SC fate. To examine this hypothesis, we performed qPCR for
the Notch target genes Hes1 and Hes5 (Zheng et al., 2000; Zine
et al., 2001). While Hes1 expression was unchanged in explants
treated either with 3 or 10 mM blebbistatin, Hes5 expression was
increased signiﬁcantly at 10 mM blebbistatin (po0.05) compared
to controls (Fig. 9F). This result is consistent with the hypothesis
that inhibition of cochlear outgrowth leads to an aberrant
increase in Notch signaling, with resulting changes to the fates
of cells within the OC (Murata et al., 2009). However, we cannot
rule out the possibility that changes in expression of Hes5 arise as
a result of prolonged contacts between HCs and SCs which occurs
in response to inhibition of extension.Discussion
While Atoh1 is known to be necessary for hair cell formation,
questions regarding the speciﬁc role of this protein have persisted
since the initial description of the inner ear phenotype in Atoh1
mutant mice. The results presented here demonstrate that up to 30%
of cells within the OC that are initially Atoh1-positive become SCs,
not HCs, conﬁrming that ATOH1 acts at the level of HC speciﬁcation,
and that Atoh1 expression does not irreversibly commit prosensory
cells to a HC fate. Rather, the onset of Atoh1 expression marks the
beginning of a dynamic temporal process in which initially low
levels of Atoh1 are gradually increased, or inhibited, through multi-
ple signaling pathways. ATOH1 is known to bind to one of its own
enhancers leading to the formation of a strong positive feedback
loop (Helms et al., 2000), while recent studies have identiﬁed several
signaling pathways, including Notch signaling, Inhibitors of differ-
entiation (Ids), Sox2, Neurogenin1, and NeuroD (Dabdoub et al.,
2008; Doetzlhofer et al., 2009; Jahan et al., 2010; Jones et al., 2006;
Kiernan et al., 2005; Raft et al., 2007), which play a role in
suppressing the activity of ATOH1. Cells able to maintain expression
of Atoh1, a process that probably requires the continued presence of
ATOH1 itself, will develop as HCs, while cells that are unable to
maintain or increase their initial Atoh1 expression fail to complete the
HC program. Although canonical Wnt signaling has been implicated,
the factors that initiate Atoh1 expression are not known, nor is the
Fig. 8. Modulation of Notch signaling alters the fates of Atoh1-positive cells. A–D. Atoh1Cre*PR; R26RtdTomato cochlear explants established at E13 and maintained for 6 DIV.
RU486 was added for the ﬁrst 24 h of culture. All images are from the 25% of cochlear length position. Explants are stained for tdTomato (magenta) and anti-MyoVIIa
(green). Open arrowheads indicate tdTomato-positive SCs, and arrows show non-tdTomato-labeled HCs. A. Control explant. B. Explant treated with 50 mM DAPT from 3 to
6 DIV. Some tdTomato, MyoVI-positive HCs are adjacent to other HCs with no apparent SCs in between; more tdTomato-negative, MyoVI-positive HCs are also observed
(arrows). Few tdTomato-labeled SCs are present (open arrowheads). C. Explant treated with 5 mg/ml control IgG2A Fc. D. Explant treated with 5 mg/ml DLL1-Fc protein,
beginning after 1 DIV. E. Percentages of all tdTomato-labeled cells exhibiting a SC morphology, and percentages of all MyoVIIa-positive cells also labeled with tdTomato.
Data are from paired explants from multiple experiments, and expressed as means7SEM. DLL1-Fc data represent the average from all explants treated with 2.5–10 mg/ml
DLL1-Fc. npo0.05, nn po0.005, nnnp o0.00001. F. Average change in the % of tdTomato-labeled cells with a SC morphology in DLL1-treated explants vs. control Fc-treated.
The increase in labeled SCs is signiﬁcant for all concentrations of DLL1 except 1.25 mg/ml (po0.05), but no dose response is evident.
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Atoh1 expression.
One signaling pathway that clearly plays a role in Atoh1
regulation is the Notch signaling pathway. Blocking Notch with
DAPT resulted in a signiﬁcant reduction in the percentage of Atoh1-
positive SCs cells, as nearly all Atoh1-positive cells within the
sensory epithelium developed as HCs. These results suggest that
many Atoh1-expressing cells that would have become SCs were
converted to HCs. Atoh1-positive SCs that remained in DAPT
treated explants were largely localized to the pillar cell (PC) region,
located between the IHCs and OHCs, consistent with recent results
(Doetzlhofer et al., 2009) that showed that PC fate is dependent on
FGF signaling, rather than Notch signaling. An increased number of
tdTomato-negative HCs were observed in DAPT-treated explants,
but it did not appear that any cells were recruited from outsidethe sensory epithelium to become HCs. The additional tdTomato-
negative HCs were found intermingled with the tdTomato-positive
HCs, rather than located near the medial or lateral edges of the OC.
Therefore, these additional HCs were presumably derived from
unlabeled, Atoh1-negative, SCs that later adopted a HC fate in
response to inhibition of Notch signaling.
In contrast, we were able to convert a smaller percentage of
Atoh1-positive HCs to SCs by adding an exogenous Notch-ligand,
DLL1-Fc. The difference in efﬁcacy of the two manipulations of
Notch activity is probably mostly due to inefﬁcient activation of
Notch signaling by the DLL1-Fc protein, but may also reﬂect the
inherent tendency of prosensory cells to adopt a HC fate. In order
to be driven towards a SC fate, a cell must be actively inhibited
from becoming a HC. Further, once a prosensory cell begins to
express Atoh1/ATOH1 robustly, it is likely difﬁcult to divert that cell
Fig. 9. Inhibition of cochlear outgrowth leads to change in fates of Atoh1-positive cells. A, B. Basal halves of E13 explants treated with 10 nM RU486 for 24 h and
maintained for 6 DIV; stained for tdTomato (magenta) and MyoVIIa (green). The control (A) shows normal extension and patterning while the paired explant, treated with
10 mM blebbistatin beginning after 1 DIV, is markedly shortened in length and disruption in cellular patterning is apparent. Dashed lines indicate position of high
magniﬁcation images in (C, D). C, D. Open arrowheads indicate tdTomato- positive SCs and arrows show tdTomato-negative HCs as in previous ﬁgures. C. Control explant.
HCs and SCs are present in ordered rows, and the separation of IHCs and OHCs is obvious. D. Blebbistatin-treated explant. The rows of HCs are disorganized, with both
regions of closely packed HCs and gaps where no HCs are present. There is no discernible separation between IHCs and OHCs. Several tdTomato-positive SCs are visible
(open arrowheads). E. Percentages of all tdTomato-labeled cells exhibiting a SC morphology, and percentages of all MyoVIIa-positive cells also labeled with tdTomato. Data
are from paired explants from multiple experiments, and expressed as means7SEM. *po0.05, **po0.01 F. Relative expression levels of Hes1 and Hes5 in blebbistatin-
treated cochlear explants. Explants were established and treated as in (A–D), and relative gene expression levels determined by qPCR after 6 DIV. Hes5 expression is
signiﬁcantly increased relative to control at 10 mM blebbistatin (po0.05). Error bars represent SEM.
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modulation of Atoh1 activity is an important consequence of Notch
signaling within the inner ear. While this had been assumed for
some time, a direct demonstration had not been presented.
Concomitant with Notch-mediated sorting of Atoh1-positive
cells into the proper mosaic of HCs and SCs is active outgrowth
and extension of the cochlear duct. Our results using the Myosin II
inhibitor blebbistatin indicate that coordination between these two
processes is important for patterning of the OC. When normal
extension of the cochlear epithelium is blocked, the proportion of
Atoh1-expressing cells that develops as SCs increases. Our hypoth-
esis that this increase in SCs is due to an increase in Notch signaling
is supported by the increased expression of the Notch target Hes5
in blebbistatin-treated explants. This suggests that the separation
of developing HCs that arises during cochlear extension acts
to limit the effects of Notch signaling, most likely as a result of
changes in the spatial relationships between developing prosen-
sory cells. Previous studies have shown that the average number of
cell contacts per HC drops from six to four as the cochlea extends
(McKenzie et al., 2004), a process that is presumably disrupted
when extension is inhibited. Finally, the observation that in
blebbistatin-treated explants Hes5, which is expressed in Dieters’
cells, increased, while Hes1, which is primarily found in Hensen’s
cells (Murata et al., 2009), was unchanged, suggests that the
increase in SCs is probably a result of HCs converting to Dieters’
cells; however, the patterning defects that arise from blebbistatin
treatment make it difﬁcult to determine speciﬁc SC phenotypes.
Regardless, these results demonstrate a direct link between
cochlear outgrowth and cell fate, implicating physicalrearrangements of developing prosensory cells as an important
factor in limiting the number of HCs within the OC.
The observation that Notch signaling was disrupted when
cochlear outgrowth was inhibited may provide a mechanistic
explanation for some of the phenotypes observed in mouse
mutants with shortened cochleae. Deletion of either Neurog1 or
FoxG1 results in cochleae that are approximately one-half of
normal length (Ma et al., 2000; Pauley et al., 2006) and while the
overall number of hair cells are reduced, patterning defects in these
mutants are comparable to phenotypes from mice with mutations
in Notch1, Dll1, Jag2, Hes1 or Hes5 (Brooker et al., 2006; Kiernan
et al., 2005; Lanford et al., 1999; Zheng et al., 2000; Zine et al.,
2001). While patterning defects in shortened cochleae almost
certainly arise simply because cells with the prosensory domain
cannot physically extend, these results suggest that disruptions in
Notch signaling may also contribute to an overabundance of hair
cells towards the apical portion of the cochlea in these mutants.
By varying the timing of CrenPR induction, we were able to
visualize a largely basal-to-apical gradient (actually initiating in
the mid-basal region) in the restriction of Atoh1-expression to HCs,
conﬁrming that determination of cell fate proceeds in a gradient
that precedes the gradient of cellular differentiation. However,
while modulation of Atoh1 expression, and subsequent effects on
cell fate appear to occur as a prolonged process that begins on E13
and is not fully completed until E17 or later, the onset of Atoh1-
expression apparently occurs much more rapidly. CrenPR induction
for as little as 1 h on E13 was sufﬁcient to label cells along the
entire length of the cochlea, including cells that would ultimately
develop as OHCs located in the extreme apex of the OC. Similarly,
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was observed, no such gradient was observed in terms of HC
speciﬁcation. These results are consistent with previous work that
reported rapid onset of Atoh1 expression along the length of the
cochlea at E13.5 based on expression of lacZ under the control of
the endogenous Atoh1 promoter (Woods et al., 2004; Yamamoto
et al., 2009). In contrast, the gradient in Atoh1 expression observed
by in situ hybridization (Lanford et al., 1999; Woods et al., 2004) or
in several transgenic Atoh1-reporter lines (Chen et al., 2002; Matei
et al., 2005) more likely reﬂects the subsequent establishment of
strong expression of Atoh1 in cells that have become committed
to develop as hair cells. The difference in timing between these
two events (the initial onset of the HC commitment program via a
uniform low level of Atoh1 expression along the length of the
cochlear duct versus the cell fate determination, commitment, and
differentiation that will not be completed in some of these cells
until E17 or later) suggests that ongoing inhibition of ATOH1 is
seemingly necessary to prevent cellular speciﬁcation and commit-
ment in more apical regions of the duct. These results are
consistent with recent work demonstrating the importance of
various pathways and molecules, including Inhibitors of differen-
tiation (Ids), Sox2, Neurogenin1, and NeuroD (Dabdoub et al., 2008;
Jahan et al., 2010; Jones et al., 2006; Raft et al., 2007), in
suppressing the activity of ATOH1. In particular, Sox2 and several
Id molecules are down-regulated in basal-to-apical gradients that
precede HC commitment.
Finally, the demonstration that ATOH1 protein is absent from the
basal HCs as early as P0, while residual Atoh1 mRNA is still clearly
detectable, suggests that additional levels of regulation of ATOH1
protein may be present. In other contexts, ATOH1 can be the target
of proteasome-mediated degradation in response to either Wnt or
Bmp signaling (Tsuchiya et al., 2007; Zhao et al., 2008). Since both of
these factors are present within the developing cochlear duct, active
degradation of ATOH1 protein may play a role in a rapid termination
of ATOH1 activity even while Atoh1 mRNA is still present within
developing HCs. While further studies are clearly required, these
results suggest intriguing new possibilities regarding the spatial and
temporal resolution of ATOH1 activity within the cochlea.Acknowledgments
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